Growth inhibition by fusidic acid in cervical, thyroid, and breast carcinoma cell lines
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
ObjectiveWe investigated the effects of fusidic acid (FA) on human cervical, thyroid, and breast carcinoma cell lines to determine the potential usefulness of FA in cancer treatment. MethodsSix cancer cell lines (cervical cancer: Caski, HeLa; thyroid cancer: 8505C, TPC1; and breast cancer: MCF-7, MDA-MB-231) were treated with FA. Furthermore the changes in cell growth, cell cycle duration, and extent of apoptosis were analyzed. ResultsAfter FA treatment, the cancer cells showed a decrease in growth rate. In the cell death assay, the cell populations were similar in each cell type after treatment with FA, indicating that growth inhibition by FA was not related to the induction of apoptosis. FA induced cell cycle arrest at a dose that inhibited growth rate, which varied in different cell types. G0/G1 phase arrest occurs in breast cancer, S phase arrest in 8505C thyroid cancer, and G2/M phase arrest in cervical cancer. These results indicate that FA reduces growth rates by inducing cell cycle arrest. ConclusionFA treatment can interfere with cell proliferation by inducing cell cycle arrest in human cervical, thyroid, and breast carcinoma cell lines. Thus, FA can be useful in treating human cervical, thyroid, and breast carcinomas.
Abstract
ObjectiveWe investigated the effects of fusidic acid (FA) on human cervical, thyroid, and breast carcinoma cell lines to determine the potential usefulness of FA in cancer treatment. MethodsSix cancer cell lines (cervical cancer: Caski, HeLa; thyroid cancer: 8505C, TPC1; and breast cancer: MCF-7, MDA-MB-231) were treated with FA. Furthermore the changes in cell growth, cell cycle duration, and extent of apoptosis were analyzed. ResultsAfter FA treatment, the cancer cells showed a decrease in growth rate. In the cell death assay, the cell populations were similar in each cell type after treatment with FA, indicating that growth inhibition by FA was not related to the induction of apoptosis. FA induced cell cycle arrest at a dose that inhibited growth rate, which varied in different cell types. G0/G1 phase arrest occurs in breast cancer, S phase arrest in 8505C thyroid cancer, and G2/M phase arrest in cervical cancer. These results indicate that FA reduces growth rates by inducing cell cycle arrest. ConclusionFA treatment can interfere with cell proliferation by inducing cell cycle arrest in human cervical, thyroid, and breast carcinoma cell lines. Thus, FA can be useful in treating human cervical, thyroid, and breast carcinomas.
참고문헌 (15)
- 하형인, "The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry", Obstetrics & Gynecology Science, 64(5), pp.444~453 (2021), 대한산부인과학회
- "Annual report of cancer statistics in Korea in 2019" (2019)[URL]
- Fernandes P, "Fusidic acid : a bacterial elongation factor inhibitor for the oral treatment of acute and chronic staphylococcal infections", Cold Spring Harb Perspect Med, 6, pp.a025437~ (2016)
- Savelsbergh A, "Distinct functions of elongation factor G in ribosome recycling and translocation", RNA, 15, pp.772~780 (2009)
- Godtfredsen WO, "Fusidic acid : a new antibiotic", Nature, 193, pp.987~ (1962)
- Harvey CL, "On the mode of action of fusidic acid", Biochemistry, 5, pp.3320~3327 (1966)
- Howden BP, "Dumb and dumber--the potential waste of a useful antistaphylococcal agent : emerging fusidic acid resistance in Staphylococcus aureus", Clin Infect Dis, 42, pp.394~400 (2006)
- Arigoni D, "The location of the ring C hydroxyl group in fusidic acid", Experientia, 19, pp.521~522 (1963)
- Yamaki H, "Inhibition of protein synthesis by fusidic and helvolinic acids, steroidal antibiotics", J Antibiot(Tokyo), 18, pp.228~232 (1965)
- Koripella RK, "Mechanism of elongation factor-G-mediated fusidic acid resistance and fitness compensation in Staphylococcus aureus", J Biol Chem, 287, pp.30257~30267 (2012)
- White SJ, "Doxorubicin generates a proapoptotic phenotype by phosphorylation of elongation factor 2", Free Radic Biol Med, 43, pp.1313~1321 (2007)
- Huizing MT, "Taxanes : a new class of antitumor agents", Cancer Invest, 13, pp.381~404 (1995)
- White-Gilbertson S, "The role of protein synthesis in cell cycling and cancer", Mol Oncol, 3, pp.402~408 (2009)
- Thornes RD, ""Fucidin"therapy in carcinoma of the breast. (Preliminary report)", J Ir Med Assoc, 58, pp.52~54 (1966)
- "Fucidin patient information leaflet" (2017)[URL]